OTC Tax Deductibility Could Gain Favor In 108th Congress
This article was originally published in The Tan Sheet
Executive Summary
CHPA believes the Republican majority in the Senate will be more willing to consider the association's proposal to make OTC drug purchases tax deductible
You may also be interested in...
GPhA legislative staffers
Generic Pharmaceutical Association adds two legislative staffers in advance of 108th Congress. VP-Policy & Public Affairs Christine Simmon joins GPhA from BlueCross BlueShield, where she served as a senior policy analyst. Suzanne Charleston is GPhA's new director of government relations; she previously held the same position at the Pharmaceutical Care Management Association. GPhA's legislative agenda is centered on modifications to Hatch/Waxman; Sen. Orrin Hatch (R-Utah), who will resume chairmanship of the Judiciary Committee, has expressed interest in considering generic drug reforms (1"The Tan Sheet" Nov. 11, 2002, p. 11)...
Hatch/Waxman Reinterpretation Underpins Change In 30-Month Stay Policy
FDA's proposal to allow only one 30-month stay of approval for ANDAs hinges on a reinterpretation of Hatch/Waxman language declaring that patent holders must be notified if a generic application is amended to "include" a Paragraph IV certification
FDA First Amendment Federal Register Notice Needs Clarification – Sen. Reed
FDA should clarify the Federal Register notice in which it asks for comments on its application of the First Amendment by issuing a second notice and extending the comment deadline, Sen. Jack Reed (D-R.I.) says in a July 16 letter to the agency